Evaluation of Adverse Events and Health-Related Quality of Life in Patients with Colorectal Cancer Receiving Ambulatory Home-Based Chemotherapy in Thailand
Not Applicable
Completed
- Conditions
- ncontrolled underlying of heart disease,DM,hypertension,and cognitive imparement
- Registration Number
- TCTR20201117001
- Lead Sponsor
- Ramathibodi Hospital, Mahidol University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 175
Inclusion Criteria
1. Colorectal cancer patient
2. Treatment: oxaliplatin/leucovirin/5-fluorouracil (mFOLFOX) and
Irinotecan/leucovirin/5-fluorouracil (FOLFIRI) with 5-fluorouracil contrnuous infusion for 48-50 hours (both regimens)
3. Good ECOG performance status <3
4. Good compliance
5. Signed consent form
Exclusion Criteria
1. Uncontrolled underlying disease
2. Cognitive impairment (it might be impacted of selfcare and device care at home)
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Health Related Quslity of Life (HRQLO) and adverse event December, 2015- November 2016 observational and comparative design
- Secondary Outcome Measures
Name Time Method none none none